debate: high risk myeloma: should it be treated differently? - yes
Published 8 years ago • 374 plays • Length 10:24Download video MP4
Download video MP3
Similar videos
-
16:35
debate: high risk myeloma: should it be treated differently? - no
-
24:06
high risk myeloma: how and should it be treated differently?
-
19:09
high-risk myeloma: how and should it be treated differently
-
12:05
debate: should dlbcl patients be treated differently based on cell of origin? - yes
-
13:34
debate: is allotransplant relevant today in myeloma? - yes
-
12:00
debate: is allotransplant relevant today in myeloma? - no
-
29:45
debate: ideal treatment fro smoldering myeloma
-
9:02
debate: to maintain or not to maintain in myeloma? - yes, use imids
-
13:10
debate: is transplant a necessity or a choice for myeloma patients? - yes
-
17:26
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (proteasome inhibitors)
-
15:31
debate: to maintain or not to maintain in myeloma? - no, but if you must, use a proteasome inhibitor
-
19:19
smoldering myeloma: who and when to treat?
-
21:18
myeloma debate: is mrd ready for prime time? - yes
-
9:19
debate: is transplant a necessity or a choice for myeloma patients? - no
-
19:56
how many myelomas are there? do we treat them differently?
-
40:06
multiple myeloma: a pathway to better outcomes
-
16:08
debate: is mrd the new primary goal for multiple myeloma treatment? - yes
-
22:15
smoldering myeloma: who and when to treat?
-
30:45
smoldering multiple myeloma – defining high risk and deciding who to treat